LeanLife Appoints Operations Manager
January 31 2019 - 2:03PM
LeanLife Health Inc. (CSE: LLP) (the “Company”) announces that the
Company has hired an Operations Manager.
The Company introduces Glenn Nichols who will
lead the buildout of LeanLife's production facility.
Mr. Nichols' involvement is part of a
company-wide reboot, where every position and expenditure is
evaluated for its strategic benefit.
He brings more than 15 years of Product and
Operations Management experience, having worked with large
multi-company teams, combined with a strong automation engineering
background.
Over the past several years he has played key
roles in the nutraceutical market bringing a manufacturing plant
operational while automating several of its complex processes to
maximize efficiencies, reduce labour requirements, and improve
product quality and consistency.
One of Mr. Nichols' primary strengths is his
ability to identify problems with current or planned products and
processes. His creative solutions have resulted in him being
named in several patents granted, pending or in the application
stage, for every company he has worked with over the past 18
years.
Mr. Nichols will continue where Ms. Liu left
off. LeanLife thanks Ms. Liu for her past service.
"LeanLife looks forward to benefiting from Mr.
Nichols' expertise as it prepares a clear path to fulfilling its
original mandate of providing a shelf-stable Omega-3 product to
meet the growing demand," said Stan Lis, CEO.
“I look forward to applying my proven expertise
in food production to LeanLife and in particular to bringing
efficiencies to its processes." said Mr. Nichols.
About LeanLife Health and the Omega-3
Market
LeanLife Health’s products are shelf-stable extractions from
flax seed, a plentiful and non-animal source of Omega-3, that give
them a significant advantage as a fortified food ingredient.
The products can be used as food additives or as nutraceuticals
and have been used to make bread, noodles, cheese, yogurt, juice
and milk products for the European market.
LeanLife Health’s industry leading Omega-3 product formulations
are of the highest quality and contain no cholesterol. Products are
available in oil, emulsion and powder forms.
The global Omega-3 market is expected to reach USD $7.32 billion
by 2020, according to a report by Grand View Research, Inc.
For more information, please contact:
Stan Lis, CEO604-764-0518SLis@LeanLifeHealth.com
Forward Looking Information
Information set forth in this news release
contains forward-looking statements that are based on assumptions
as of the date of this news release. These statements reflect
management's current estimates, beliefs, intentions and
expectations. They are not guarantees of future performance. The
Company cautions that all forward looking statements are inherently
uncertain and that actual performance may be affected by a number
of material factors, many of which are beyond the Company's control
including, the Company's ability to compete with large food
companies; sales of any potential products developed will be
profitable; the ability to complete sales under the sales
agreement. Accordingly, actual and future events, conditions
and results may differ materially from the estimates, beliefs,
intentions and expectations expressed or implied in the
forward-looking information. Except as required under applicable
securities legislation, the Company undertakes no obligation to
publicly update or revise forward-looking information.
THE CSE HAS NEITHER APPROVED NOR
DISAPPROVED THE INFORMATION CONTAINED HEREIN AND DOES NOT ACCEPT
RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS
RELEASE.
LeanLife Health (CSE:LLP)
Historical Stock Chart
From Nov 2024 to Dec 2024
LeanLife Health (CSE:LLP)
Historical Stock Chart
From Dec 2023 to Dec 2024
